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Background: Both cell-free and cell-associated infection routes are important for retroviral dissemination.
Regardless of the mechanism, the driving force of retroviral entry is the interaction between the viral envelope and
its receptor. To date it remains unclear how decreased affinity of viruses for their receptors affects viral cell-free
infection, cell-cell transmission, and spreading kinetics. We have previously characterized a mutant form of the
amphotropic murine retrovirus receptor human phosphate transporter 2 (PiT2) wherein the single substitution of a
glutamic acid for the lysine residue at position 522 of this receptor is sufficient to render it to function as a gibbon
ape leukemia virus (GALV) receptor.
Results: In this study we analyzed the binding affinity of the mutant receptor PiT2K522E and determined that it has
a 1000 fold decreased GALV envelope binding affinity compared to the GALV wild type receptor. The decreased
affinity does not restrict the initiation of cell-free GALV infection. The diminished binding affinity does, however,
correlate with a decrease in the ability of GALV to spread in cells expressing this mutant receptor.
Conclusions: The reduced ability of GALV to subsequently spread among cells expressing PiT2K522E is likely
resulted from reduced cell-cell transmission, the decreased ability of PiT2K522E-expressing cells to establish
superinfection interference, and attendant cytopathic affects.Background
Both cell-free and cell-associated infections are impor-
tant for retroviral dissemination. However, cell-
associated viral infection is over a thousand fold more
efficient in vivo [1]. To enter cells, cell-free enveloped
viruses bind to specific receptors on the target cell sur-
face. They then penetrate the host cells by either direct
fusion of viral and cellular lipid membranes or via an
endocytotic pathway. Both entry pathways result in the
release of the viral nucleocapsid into the cytoplasm [2-
4]. Several mechanisms have been invoked for the trans-
mission of virus from an infected cell to an uninfected
cell. All involve the interaction of viral envelope in the* Correspondence: eidenm@mail.nih.gov
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reproduction in any medium, provided the ormembrane of the infected cell with the receptor on the
uninfected target cell triggering a signal that causes cyto-
skeleton rearrangement. Several adhesion molecules are
recruited to participate at the cell contact site to form a
virological synapse and filopodial bridges [5-7].
The affinity thresholds that accompany the association
of viral envelope proteins in the membrane of infected
cells with their receptors required to trigger viral entry
vary greatly. Influenza virus requires millimolar range af-
finity while human immunodeficiency virus (HIV)
requires binding affinity in the nanomolar range [1].
Higher affinities result in more efficient binding of a sin-
gle viral particle to recruit several receptors thereby ac-
celerating post-binding events that lead to membrane
fusion and enhance efficiencies of viral entry. In cell-
associated infection routes, envelope proteins are highly
enriched on the infected cell interface. This enrichment
allows more efficient recruitment of receptors and sub-
sequent access to signaling proteins at levels that make
cells more susceptible to viral replication. For example,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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motion [7] and cellular proteins that interact with the
host cell cytoskeleton [8] to support intracellular trans-
port and membrane fusion events associated with viral
entry. Decreased affinity between viral envelope and re-
ceptor has been reported to cause delayed viral replica-
tion kinetics and is linked to the failure to establish
superinfection resistance, apoptosis, and induce syncytia
formation [9-12]. However, it remains unclear how a
decreased receptor affinity affects viral cell-associated in-
fection and spreading kinetics.
As gammaretroviruses, amphotropic murine leukemia
virus (A-MLV) and gibbon ape leukemia virus (GALV)
have divergent host ranges and are not in the same in-
terference class [13]. The receptors for GALV and A-MLV
encode distinct but related proteins originally designated
GLVR1 and GLVR2 [13]. Later, the GALV and A-MLV
receptors were identified to function as type III inor-
ganic phosphate transporters and renamed as PiT1 and
PiT2 and are now referred to as SLC20A1 and SLC20A2
in accordance with their transporter classification. Herein,
we use the PiT1 and PiT2 nomenclature for ease of
cross-referencing. Previously, we reported that the PiT2
ortholog expressed on hamster E36 cells, HaPiT2, in con-
trast to the human form of the A-MLV receptor (PiT2),
functions as a receptor not only for A-MLV, but also
GALV [14]. Based on comparison of the deduced amino
acid sequences of the HaPiT2 and PiT2 proteins, it was
eventually determined that the substitution of a single
amino acid residue, glutamate (glutamic acid), for lysine
residue at position 522 is sufficient to render PiT2 func-
tional as a GALV receptor while retaining A-MLV recep-
tor function. The titer of GALV enveloped retroviral
vector is reduced 5 to 6 fold in cells expressing theFigure 1 The kinetics of GALV replication in MDTF cells expressing HA
lines) or MDTFPiT2K522E-HA (lower three lines) cells were exposed to 1ml (o
of polybrene. Cells were harvested for flow cytometry analysis at day 1, 2, 4,
each time point, day postinfection (dpi). The experiments were repeated thrmutant receptor PiT2K522E compared to those expres-
sing the GALV receptor PiT1 [15,16].
Although both PiT1 and PiT2K522E function to effi-
ciently mediate transduction by GALV enveloped vectors,
the ability of PiT2K522E to function as a receptor for
replication-competent GALV has not been previously
characterized. Surprisingly, PiT1 and PiT2K522E function
very differently in their ability to bind GALV envelope, es-
tablish superinfection resistance and facilitate efficient
GALV spread following exposure to cell-free virus.
Results
Productive infection by GALV is severely restricted in cells
expressing PiT2K522E compared to cells expressing PiT1
Although both PiT1 and PiT2K522E confer susceptibility
to GALV vectors, the ability of PiT2K522E to support in-
fection by replication-competent GALV has not been eval-
uated. We, therefore, assessed the capacity of MDTF cells
expressing PiT2K522E compared to PiT1 receptors to fa-
cilitate viral spread after exposure to cell-free virus.
Replication-competent, GFP expressing virus with a
GALV envelope [17] was used to assess GALV cell-to-cell
transmission in vitro. MDTF cells are resistant to GALV.
MDTF cells expressing PiT1 or PiT2K522E were exposed
to 0.05, 0.2 or 1 ml of supernatant from productively
infected GALV-GFP 293 T cells. Every 2 to 3 days, cells
were harvested for flow cytometry (FACS) analysis and
then further subcultured. As shown in Figure 1, GALV
spread rapidly in MDTFPiT1-HA cells. Around 4–5% of
MDTFPiT1-HA cells exposed to 0.05 ml GALV-GFP were
infected 24 h post-exposure, and maximum infection
(93%) was reached at 9 days post-exposure. When the viral
inoculums were increased to 0.2 ml or 1 ml, the percent
of cells infected correspondingly increased to 26% andMDTFPiT2K522E-HA
MDTPiT1-HA
epitope tagged PiT1 or PiT2K522E. MDTFPiT1-HA (upper three
), 0.2ml (□) or 0.05ml (△;) of GALV-GFP viral supernatant in the presence
7, 9, 11, 14 and 30. The percentage of GFP positive cells is displayed at
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Figure 2 The binding affinity of GALV RBD with MDTF cells expressing HA tagged PiT1, PiT2K522E or PiT2. GALV RBD tagged with both
V5 and His was purified using high-performance nickel-NTA (Ni-NTA) agarose, serially diluted four times and applied to a binding assay for
MDTFPiT1-HA (A) or MDTFPiT2K522E-HA and MDTFPiT2-HA cells (B). The kinetics of binding of GALV RBD was compared. The mean fluorescence
intensity (MFI) for GALV RBD binding is indicated on the y-axis and GALVRBD concentration (mg) on the x-axis. Three independent experiments
were performed and the mean ± standard deviation was presented in the curve.
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reached by day 7 or 9 (Figure 1). GALV spread in cells
expressing K522EPiT2 did not exhibit an ability similar to
that shown in cells expressing PiT1 where >90% of the
cells were productively infected. Infection of MDTF cells
expressing the mutant receptor resulted in an initial rela-
tively slow spread of virus in the cultures culminating in a
peak of infected cells at day 7 to 9 depending on the ini-
tial inoculums (Figure 1). On the first day post exposure,
only 3%, 9% or 16% of MDTF cells expressing PiT2K522E
were infected when exposed to 0.05, 0.2 or 1 ml GALV-
GFP supernatant, respectively. Infection peaked with ap-
proximately 40% of cells infected with GALV. After this
peak at day 7 or 9, the number of GALV-GFP infected
MDTFPiT2K522E-HA cells gradually diminished. To de-
termine if the mutant receptor instability restricts GALV
spread, we examined PiT2K522E expression on the sur-
face of MDTF cells by flow cytometry analysis 3 weeksafter GALV-GFP exposure. PiT2K522E protein remains
stably expressed on the surface of both uninfected and
infected cells (Additional file 1: Figure S1). This result
indicates that restriction of GALV spreading is not due to
PiT2K522E instability.
Even though CHOK1, like E36 cells, are derived from
Chinese hamsters, these two cell types differ in their resist-
ance to infection by GALV: CHOK1 cells are resistant to
GALV [14,18]. CHOK1 cells (Chinese hamster kidney
cells) expressing either PiT1 or PiT2K522E employed in
parallel studies showed similar results (data not shown).
PiT2K522E exhibits a markedly reduced ability to bind
GALV compared to wild type PiT1
To further characterize the unusual features of this mu-
tant receptor, we performed SU (the surface component
of mature envelope protein) binding assays. Full length
GALV SU, in contrast to MLV and FeLV SUs, is not
36 hours 48 hours
Figure 3 GALV is release efficiency from MDTF cells expressing
PiT1 or PiT2K522E. MDTF cells expressing receptor PiT1 or
PiT2K522E were incubated with 0.5ml GALV-GFP viral stock at 37°C
for 1 hour, then the cells were extensively washed and maintained
in culture. Media were collected at two time points, 36 and 48 hours
after initial exposure to GALV. The titer of GALV-GFP viruses present
in 36 hours or 48 hours samples, were assayed by exposing MDTF
cells expressing PiT1 to supernatant and performing FACS analysis to
determine the percentage of GALV-GFP infected cells at 30 hours
after viral exposure. The experiments were repeated three times
independently and averaged values are shown.
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subunit of the GALV SU encoding the first 219 residues of
processed SU and encompassing the receptor binding
domain (RBD) and proline rich region (PRR) is expressed
and specifically binds PiT1 [15]. We, therefore, employed
this 219 residue GALV RBD bearing a V5 epitope tag to
detect GALV binding to cells expressing various recep-
tors. Murine MDTF cells are resistant to GALV whereas
MDTF cells expressing PiT1 or PiT2K522E are suscep-
tible to GALV. GALV RBD was purified, serially diluted
and incubated with MDTF cells expressing hemagglutinin
(HA) epitope tagged PiT1, PIT2K522E or PiT2 as de-
scribed in Materials and Methods. As shown in Figure 2A,
0.16μg of GALV RBD was sufficient to obtain 50% bind-
ing to MDTFPiT1-HA cells. In contrast, 160μg of purified
GALV RBD was required to achieve similar binding to
MDTFPiT2K522E-HA cells (Figure 2B). Thus, a thousand-
fold increase in GALV RBD is required to achieve similar
binding with cells expressing PiT2K522E-HA compared
to MDTFPiT1-HA cells.
Nonspecific binding of murine leukemia virus (MLV)
particles to cells has been previously reported [19-21].
To determine if the binding of GALV to MDTF cells ex-
pressing PiT2K522E is nonspecific, we examined GALV
RBD binding to MDTF cells expressing PiT2 that are
not susceptible to GALV infection. As shown in Figure 2B,
binding of GALV RBD to MDTF cells expressing PiT2
was significantly lower than that achieved with MDTF
cells expressing PiT2K522E. These results indicate that
MDTF cells expressing PiT2K522E bind to GALV RBD
at a substantially reduced affinity compared to MDTF
cells expressing PiT1, but still at a level sufficient to fa-
cilitate GALV entry.
Cells expressing mutant receptor are not deficient in their
ability to release infectious particles
To investigate whether the decrease in the ability of
GALV to spread in cells expressing PiT2K522E is
caused by deficiencies in viral particle assembly or re-
lease, we performed viral release assays as described in
Materials and Methods. MDTF cells expressing PiT1 or
PiT2K522E were incubated with GALV-GFP viruses at
37°C for 1 h, and then the cells were extensively washed
and maintained in culture. Media were collected at two
time points, 36 and 48 h after initial exposure to repli-
cation competent GALV-GFP and the titer of the
released virus present in supernatant was assessed by
exposing MDTF cells expressing PiT1 to supernatant
and 30 h later performing FACS analysis to determine
the percentage of GALV-GFP infected cells. As shown
in Figure 3, the titer of viruses released from GALV-
GFP infected MDTF cells expressing PiT1 or
PiT2K522E was similar based on the percentage of GFP
positive cells. Thus, decreased viral receptor bindingaffinity does not affect infectious particle assembly or
release.
Decreased GALV binding affinity to the mutant receptor
leads to failure to establish superinfection resistance
It has been previously reported that a decreased affinity
of interaction between viral envelope protein and recep-
tor results in apoptosis, syncytia formation or cytopathic
effects (CPE) due to a failure to establish superinfection
protection [9]. Therefore, we designed an experiment to
assess whether the decreased affinity of mutant receptor
results in diminished superinfection resistance.
MDTFPiT1 cells and MDTFPiT2K522E cells were
infected with GALV-GFP. Two weeks later, they were
exposed to GALV enveloped vectors expressing the
fluorescent marker protein cherry red (GALV-RFP). As
shown in Figure 4A and 4B, only 0.84% GALV-GFP
infected MDTFPiT1 were susceptible to GALV cherry
red vectors. In comparison, 21.3% of MDTFPiT2K522E
cells infected with GALV-GFP remained susceptible to
GALV-RFP vectors (Figure 4C and 4D), demonstrating a
failure to establish superinfection interference in GALV
infected MDTFPiT2K5222K. These results are summar-
ized in the table at the bottom of Figures 4.
GALV transmission from infected MDTFPiT1K522E to
uninfected cells expressing PiT2K522E tagged with HA is
not defective but is diminished
To further resolve whether the reduced number of
MDTFPiT2K522E cells productively infected with GALV
18.9094.60R5+R6=GFP+  (%)
21.30.84Cells that fail to establish superinfection 










Yes No Replication-competent GALV-GFP infection
MDTFPiT2K522E
Replication-deficient GALV-RFP challenge Yes Yes 
R6=GFP + and RFP+ (%) 0.1 5.1
R4=RFP+ (%) 42.4 24.0




























GFP expression intensity 
GALV-GFP infected MDTFPiT1 


































 GFP expression intensity
D.
Figure 4 MDTF cells expressing PiT2K522E cells fail to establish GALV superinfection resistance in. MDTF cells mock infected or infected
with GALV-GFP for two weeks, were challenged with GALV enveloped retroviral vector expressing the fluorescent marker protein, cherry red
(GALV-RFP). Two days later, cells were harvested for FACS analysis. MDTFPiT1 cells uninfected (A) and infected with GALV-GFP (B), MDTFPiT2K522E
cells uninfected (C) or infected with GALV-GFP (D). The x-axis represents MFI of GFP expression and the y-axis represents MFI of RFP expression.
Three experiments were performed and representative images were presented. Region statistics was also exhibited as R3, R4 and R5. R3 = GFP
negative and RFP negative, R6 = GFP positive and RFP positive and R5 = GFP positive but RFP negative. The statistics are listed in the table below
the figure. The percentage of cells that fail to establish superinfection resistance was calculated by the value in R6 divided by the total values in
R6 and R5.
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whether GALV can be efficiently delivered to MDTF
cells expressing PiT2K522E by co-culturing these cells
with cells productively infected with GALV. Co-culture
has historically been used to propagate several retro-
viruses and study viral cell-cell transmission pathways
[22]. To evaluate whether GALV infected cells can trans-
mit virus to uninfected MDTFPiT2K522E, we performed
a co-culture experiment. MDTF cells expressing PiT1
were exposed to GALV-GFP and grown for one week,
and then FACS analysis was performed. About 90% of
the target cells were infected (GFP positive, Figure 5A).
GALV infected MDTFPiT1 cells were then co-culturedwith recipient MDTF cells expressing HA tagged PiT1
or PiT2K522E receptors, at a one-to-one ratio. Twenty-
four hours post-exposure to virus infected cells, the cells
were harvested, stained with monoclonal HA antibody
to detect the HA-tagged viral receptors and analyzed by
flow cytometry. As shown in Figure 5 and summarized in
Table 1, GALV was transmitted to 95% of MDTFPiT1-HA
target cells (Figure5B)and to85%of theMDTFPiT2K522E-
HA target cells (Figure 5C). The spread of GALV-GFP
to both populations of target cells indicates that cells
expressing mutant PiT2K522E receptor can be effi-
ciently infected when co-cultured with GALV-producing
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C. R4=85% cells with 
HA+ and GFP+
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with recipient cells, MDTFPiT2K522E-HA
Figure 5 (See legend on next page.)
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Figure 5 Evaluation of the efficiency of GALV cell-cell transmission in co-culture experiments with MDTFPiT1 cells productively
infected with GALV expressing GFP (GALV-GFP). MDTFPiT1 cells were exposed to GALV-GFP and then maintained and cultured for one week
before being analyzed by FACS for GFP expression (A). Next GALV-GFP producer cells were co-cultured with MDTF cells expressing an HA
epitope tagged PiT1 and analyzed by FACS for GFP and HA expression (B) or MDTF cells expressing the HA epitope tagged mutant receptor
PiT2K522E and analyzed by FACS for GFP and HA expression (C). Approximately 24 hours after co-culture, cells were harvested for FACS analysis.
The MFI of HA expression is indicated on the y-axis and the MFI of GFP expression is on the x-axis. Three independent experiments were
performed and representative images presented.
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can efficiently transmit GALV to MDTF cells expressing
HA-tagged PiT1 or PiT22K522E. As shown in Figure 6,
even though only 35% of MDTFPiT2K522E cells were
productively infected with GALV (Figure 6A), the virus
was efficiently transmitted to MDTFPiT1 target cells in
a co-culture experiment (90% recipient cells were in-
fected) (Figure 6B) whereas only 45% of MDTFPiT2K522E
target cells were infected following a similar co-culture
experiment (6C). These results, summarized in Table 1,
suggest that productively infected MDTFPiT2K522E
cells can efficiently transmit GALV to target cells expres-
sing PiT1 but are substantially less efficient at transmit-
ting virus to target cells expressing PiT2K552E. Thus
cell-cell transmission of GALV infectedMDTFPiT2K522E
to cells expressing the mutant PiT2K522E is diminished
when compared to transmission of GALV from cells
expressing PiT1.
Virological synapses were observed at a reduced
frequency in GALV infected cells expressing PiT2K522E
compared to those expressing PiT1
The interaction between viral envelope glycoprotein
present on infected cells and receptors on uninfected
cells drives gag accumulation, triggers de novo viral as-
sembly at the cell-cell contact site and subsequently
transfers de novo assembled viral particles to uninfected
cells via the virological synapse or filopodia bridge ma-
chinery [5-7,23]. To confirm virological synapse forma-
tion at the contact site, 293 T cells producing the GALV
particles containing YFP labeled gag protein particles
(GALV-gag-YFP, as described in Materials and Methods)
were used to produce YFP labeled GALV and co-
cultured with recipient cells labeled with cell tracker
CMAC. CMAC is a fluorescent chloromethyl derivative
that can freely diffuse through the membranes of live
cells. Once inside the cell, CMAC reacts withTable 1 Summary of coculture experiments








MDTFPiT2K522E-HA 45%intracellular components to produce fluorescent viable
cells for at least 24 h. Six to eight hours after co-culture,
cells were examined under a confocal microscope. As
shown in Figure 7A, accumulation of gag-YFP protein at
virological synapses was observed at the contact site of
GALV producing 293 T cells (green) and MDTF cells
expressing PIT1 (blue), and similar structures were also
observed at the contact site of GALV producing cells
with MDTF cells expressing mutant receptor (Figure 7B).
We did not observe gag-YFP accumulation at the cellu-
lar contact sites when GALV-gagYFP producing 293 T
cells were co-cultured with MDTF cells expressing PiT2
(data not shown). We observed that a single donor cell,
GALV-gag-YFP producing 293 T cell, can contact more
than one recipient MDTFPiT1 cell as well as more than
one MDTFPiT2K522E cell via a long filopodia-like pro-
trusion observed on donor cells when cocultured with
both cell lines; this is marked as a white arrow in
Figure 7A. Virological synapses were observed at almost
all contact sites when cocultured with MDTFPiT1 re-
cipient cells (Figure 7A), but not at all contact sites with
MDTFPiT2K522E cells (Figure 7B). The results indi-
cated that virological synapses or filopodia bridges were
formed in cells expressing mutant receptors at a de-
creased efficiency. Thus two lines of evidence, from co-
culture experiments assessing viral transmission and from
confocal microscopic analyses, confirmed the reduced
ability of productively infected MDTFPiT2K522 cells to
efficiently transmit virus in co-culture experiments.
Syncytium formation is prominent in productively
infected cells expressing PiT2K522E
We next investigated whether the absence of superinfec-
tion interference played a role in the reduced ability of
GALVtoestablishproductive infection inMDTFPiT2K522E
cells compared with levels demonstrated by GALV em-
ploying PiT1 to infect cells. Superinfection has been linked
to apoptosis and CPE for several retroviruses [10,12]. We
hypothesized that GALV superinfection may contribute
to apoptosis that in turn results in diminished viral spread.
To test this hypothesis, we utilized PE conjugated Annexin
V as well as 7ADD to detect apoptosis in infected cells.
Annexin V is a phospholipid binding protein. The appear-
ance of phosphatidylserine (PS) is one of the early struc-
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Figure 6 (See legend on next page.)
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Figure 6 Efficiency of GALV cell –cell transmission in co-culture experiments where MDTFPiT2K522E cells infected with GALV (A) were
used as GALV producing cells, and co-cultured with MDTFPiT1-HA (B) or MDTFPiT2K522E-HA (C). Three independent experiments were
performed and representative images were presented.
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PS at high affinity. 7ADD is used to examine late cell
death. We did not detect significant cell death of GALV-
GFP infected cells expressing mutant receptor (data not
shown), and thus it does not appear that apoptosis of
superinfected cells plays a role in limiting cell spread in
GALV infected cells expressing PiT2K522E. However, we
did detect a feature that distinguishes cells expressing
PiT2K522E from those expressing PiT1 after GALV infec-
tion. An increased ability to form syncytia was observed in
MDTFPiT2K522E cells productively infected with GALV.
Seven days post exposure to GALV, the number of in-
fected MDTFPiT2K522E cells begins to decrease as shown
in Figure 1. Concomitant with the initiation of the reduc-
tion in the percentage of MDTFPiT2K522E infected cells,
is an increase in the number of multinucleated cells dem-
onstrated by comparison of number of syncytia at day 7 inB.
A.
Figure 7 Gag accumulates at the contact site of GALV producing cells
the YFP labeled gag (Gag-YFP) expressing construct and, 16 hours post tran
MDTFPiT1-HA cells (A) or MDTFPiT2K522E-HA cells (B) labeled with CMAC
virological synapse formation (yellow arrows) by confocal microscopy. The
contract site and used for viral assembly so that the GALV particles contain
cells.these two infected cell lines (Figure 8). Around 2.3%
GALV infected MDTFPiT2K522E were multinucleated
(> 3 nuclei/cell), but no syncytia were observed at a simi-
lar time point with MDTFPiT1 infected cells nor in the
initial days following MDTFPiT2K522E exposure to
GALV. Altogether, our results indicate that the decreased
affinity of mutant receptor binding to GALV correlates
with the failure to productively infect the majority of cells
expressing PiT2K522E receptors. Instead of greater than
90% of the cells becoming infected, as is the case for
human cells or resistant murine MDTF/CHOK1 cells
expressing PiT1, infection of cells expressing PiT2K522E
is restricted to approximately 35% of the cell population.
This restriction in productive infection also correlates
with the diminished ability to establish superinfection re-
sistance, a reduction in the number of virological synap-
ses, and enhanced syncytia formation.and recipient cells. GALV infected 293T cells were transfected with
sfection, used as donor cells and co-cultured with recipient,
(blue). After being co-cultured for 6 hours, the cells were examined for
Gag-YFP proteins (green) are recruited to the donor and recipient






Syncythia formation (%) 2.3% 0
Figure 8 Syncytia formation observed in MDTFPiT2K522E cells infected with GALV-GFP. MDTFPiT2K522E (A) or MDTFPiT1 cells (B) were
exposed to GALV-GFP viruses. Four days after viral exposure, Several GFP positive syncytia were observed in MDTFPiT2K522E cells and the
number of syncytia gradually increased over time. The experiments were performed three times and the representative images from cells
infected with GALV-GFP seven days after viral exposure are shown. Syncytia were defined as those cells containing three or more nuclei. The total
number of nuclei in syncythia cells was then counted. Five random fields were counted from each well of triplicate samples, using a 10x
objective [11].
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Cell lines derived from Chinese hamster lung fibroblasts
such as E36 cells are the only hamster cells susceptible
to both GALV and A-MLV. They also express a PiT2
ortholog that functions as a GALV receptor [13]. Cells
expressing human PiT2 are not permissive for GALV in-
fection nor does human PiT2 bind GALV RBD or GALV
viral particles. Using chimeric E36 hamster PiT2 and
human PiT2 proteins, we previously determined that a
single residue difference at position 522 of PiT2 ac-
counts for the ability of hamster PiT2 to facilitate GALV
as well as A-MLV entry [14]. This difference represents
the presence of a glutamate residue in hamster PiT2 in
place of the lysine residue present in PiT2. However, we
have now determined that even though resistant cells
such as murine MDTF cells expressing PiT2K522E, like
MDTF cells expressing the human GALV receptor PiT1,
are susceptible to GALV vectors, their ability to support
infection by replication-competent GALV differ dramat-
ically. In this report, we have attempted to determine
what accounts for these differences.
The reduced affinity of the PiT2K522E mutant recep-
tor to GALV compared to wild type PiT1 correlates with
a reduced capacity for viral spread (Figures 1 and 2). We
have shown that GALV infectious particles produced in
cells expressing PiT2K522E are released into the super-
natant at levels comparable to PiT1 expressing producer
cells (Figure 3). This observation together with the dra-
matically reduced ability of PiT2K522E to bind GALV
envelope suggests that infectious GALV particles are ef-
ficiently produced from cells bearing this mutant recep-
tor and that the reduction in cell-to-cell transmission is
not mediated by reduced virus production or particlestability. The weak affinity of GALV for target cells bear-
ing PiT2K522E may limit virus spread due to a failure to
recruit sufficient levels of receptor and induce conform-
ation changes necessary to mediate viral uptake via viral
synapse formation [24]. The most efficient means of
retrovirus spread following exposure to cell-free virus
involves the transfer of viral particles from infected cells
to uninfected target cells via viral synapses formed at the
interface of these two types of cells [6,7,23-25]. GALV
producer cells co-cultured with MDTFPiT1 efficiently
triggered the formation of virological synapse mediating
the apparent transfer of virus from one donor to, on
average, three recipient cells in co-culture experiments.
Similar experiments carried out with PiT2K522E expres-
sing recipient cells showed a reduction in the ratio of
donor to recipient cells (e.g., 1:1) and a reduction in syn-
apse formation (Figure 7). Efficient cell-cell transmission
is dependent on the formation of virological synapses or
filopodia bridges that, in turn, depends on virus being ef-
ficiently maintained on the cell surface by receptors
prior to extracellular release or retained in cells that fail
to release mature viral particles [24]. Cells expressing
PiT2K522E form virological synapses or filopodia
bridges less efficiently than cells expressing PiT1and this
may account for the reduced levels of productively in-
fected cells (Figure 1). We have shown previously, that
cell-free GALV pseudotyped retroviral vectors transduce
cells expressing PiT2K522E five times less efficiently than
cells expressing PiT1 [16]. The results presented here
show that cell to cell transmission is also diminished in
PiT2K522K infected cells indicating that reduced recep-
tor binding affinity affects both GALV cell-free and cell
to cell transmission.
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to specific residue changes in the envelope has been
shown to affect the cell fusion process and the spectrum
of disease associated with ecotropic murine and feline
retroviruses. It has been reported that adaptive changes
in the envelope protein of gammaretroviruses that con-
fer changes in receptor binding properties (compared to
their prototypic equivalents) correlate with altered dis-
ease properties. A recent report characterized a feline
leukemia virus subgroup A (FeLV A) isolate, FeLV-945,
that causes an uncharacteristic disease and demonstrated
that it has a significantly greater receptor binding cap-
acity than the prototypic FeLV-A, FeLV61E [26]. It was
proposed that this enhanced receptor affinity might
serve to increase the kinetics of virus spread and render
target cells with reduced receptor numbers susceptible
to infection in vivo thereby altering the disease status of
infected cats. At the opposite end of the spectrum, a
finding similar to the results presented here, has been
reported by S.L. Murphy et al. [10]. This group found a
linkage of specific residue changes in the ecotropic MLV
ENV (TR1.3) that lead to decreased receptor affinity, the
loss of superinfection resistance, syncytium formation
[27] and attendant pathology.
In this report, we demonstrate that a single virus,
GALV, can exhibit distinct receptor affinity, superinfec-
tion interference properties, syncytium formation and
viral spreading capacities depending on the receptor that
is employed to enter cells. Thus the receptor ortholog or
the envelope protein can mediate dramatic differences in
receptor dependent properties with as little as a single
residue difference as shown in this paper and previous
studies [26]. The cell lines expressing low affinity and
high affinity GALV receptors (MDTFPiT2K522E and
MDTFPiT1, respectively) employed in the analysis of
viral infection and spread are useful tools in dissecting
specific stages critical to cell-cell transmission. These
cells should prove valuable for in vitro testing of
reagents designed to prevent cell mediated viral spread.
Methods
Cell culture
Cell lines used in this study include Mus dunni tail
fibroblasts MDTF [17], Chinese hamster ovary (CHOK1)
cells, CCL61, (ATCC), and 293 T (formerly referred to
as TSA cells) [28]. All cells, with the exception of
CHOK1, were maintained in Dulbecco’s modified Eagle’s
medium with Glutamax (DMEM) (Invitrogen), supple-
mented with 10% fetal bovine serum, 100 units of peni-
cillin/ml, and 100 ug/ml of streptomycin. CHOK1 cells
were maintained in alpha minimal essential medium
(MEM) supplemented with 10% fetal bovine serum, 100
units/ml, of penicillin and 100 ug/ml of streptomycin
(Invitrogen). The GALV viral receptor PiT1, A-MLVviral receptor PiT2 and mutant receptor PiT2K522E all
tagged with a hemagglutinin (HA) eptitope were gener-
ated as previously described [16]. Vesicular stomatitis
virus (VSV) G protein-enveloped retroviral vector
pLNSX [29] expressing the appropriate receptors was
used to transduce respective cell lines and G418 allow-
ing selection of cells stably expressing these receptors.
Plasmids
The GALV-GZAP (generously provided by Christopher
Logg, University of California, Los Angeles, CA,) is
replication-competent ecotropic Moloney MLV backbone
in which the GALV env gene replaces the MLV env gene.
In addition an IRES driven GFP (IRES-GFP) is positioned
between the 3′terminus of the env gene and untranslated
region of 3′LTR [29]. The GALV-GZAP variant, MSA2-
GFP [18] contains an insertion of TCC at the MLV splice
acceptor and was shown to replicate more efficiently than
GALV-GZAP and was thus used as the GFP expressing
GALV enveloped virus in this study. We further modified
the MSA2-GFP plasmid removing the IRES-GFP fragment
and this construct was used to produce GALV enveloped
virus that does not express GFP. The GALV RBD fragment
was inserted into the pcDNA3.1-V5-His B plasmid (Invi-
trogen). Fragments encoding envelope residues 1 to 219 of
GALV RBD were amplified by PCR from the GALV enve-
lope subclone [16] using primers containing EcoRI and
XbaI at their 5′ and 3′ termini, respectively. The EcoRI
and XbaI-digested PCR product was ligated into the
pcDNA3.1-V5-His B plasmid. To construct a vector gen-
ome expressing fluorescent cherry red protein, RFP, the
GFP gene in the retroviral vector, pRT43.2 GFP [30] was
removed by digesting with PmlI (blunted) and NotI and
this fragment was removed and replaced with RFP gene
that was obtained from CMV-brainbow 1.1 M plasmid
(Addgene, Inc.) cleaved by BglII (blunted) and NotI. All
constructs generated by PCR were verified by nucleotide
sequence analyses.
Production of replication-competent retroviruses,
retroviral vectors and GALV RBD
The GALV enveloped replication-competent retroviruses
(GALV-GFP and GALV), GALV enveloped retroviral vec-
tors as well as GALV RBD were produced by calcium
phosphate transfection of 293 T cells (Promega Corpor-
ation) as previously described [31]. Supernatants were har-
vested 48 to 72 h post-transfection, then passed through a
0.45 mM Millipore (Millipore Corporation) and stored at
−80 °C. GALV RBD purification was performed following
manufacturer’s instruction (Invitrogen) with modifications.
Supernatants that contain GALV RBD tagged with V5 and
6xHis epitope were concentrated greater than 10-fold
using Amicon Ultra-15, centrifugal filters (Millipore Cor-
poration), then mixed with 40 ml binding buffer (1x Hanks
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10 mM imidazole (ACROS). Five ml samples were loaded
onto the high-performance nickel-NTA (Ni-NTA) agarose
column (Invitrogen), unbound proteins were removed with
washing buffer (1x HBSS containing 20 mM imidazole) and
bound GALV RBD was eluted with buffer (1x HBSS con-
taining 250 mM imidazole) and collected. The concentrated
GALV RBD was passed through Econo-Pac 10DG desalting
column to remove imidazole (BioRad Life Science). The
purified GALV RBD was quantified using the BCA protein
assay kit (Pierce) and stored in aliquots at −80 °C.
Co-culture of GALV infected cells with target cells
MDTFPiT1 or MDTFPiT2K522E cells were exposed to
replication-competent GALV-GFP viruses. One week after
initial exposure, infected cells were mixed with an equivalent
number of uninfected MDTFPiT1-HA or MDTFPiT2K522E-
HA cells. Thirty hours after co-culture, HA-tagged recep-
tors were detected on the cell surface by incubation of
MDTF cells expressing receptors with monoclonal HA
antibody HA.11 (Covance Inc.), followed by incubation
with a RPE conjugated secondary antibody (Santa Cruz
biotechnology) and then analyzed by flow cytometry.
Production of GALV-gag-YFP viruses and visualization of
virological synapses
Approximately 2×105 293 T cells were exposed to
replication-competent GALV viruses for one week, grown
overnight on a 35 mm tissue culture dish with a 0.17 mm
thick glass bottom, and then transfected with 0.2ug MLV-
gag-YFP plasmid. MLV-gag-YFP consists of MLV gag pro-
tein fused in frame to YFP at the nucleotides encoding the
residues PQ at present at the C-terminus of its gag nu-
cleocapsid domain (Addgene Inc.). Sixteen hours later,
these cells were incubated with 2×105 uninfected
MDTFPiT1-HA, MDTFPiT2K522E-HA or MDTFPiT2-HA
cells labeled with CMAC cell tracker blue (Invitrogen)
according to manufacturer’s instructions. The de novo
synthesized gag-YFP proteins in the infected 293 T cells
were recruited and used in GALV assembly to produce
GALV virions that contain YFP labeled gag at cell-cell
contact site. Six hours after co-culture at 37 °C, cells
were fixed with 2% paraformadehyde in PBS solution and
visualized on an LSM510 inverted Meta confocal micro-
scope (Carl Zeiss, Thornwood, NY) with a 63× 1.4 NA
oil immersion objective. CMAC was excited with a
405 nm laser, YFP with the 514 nm line of a krypton/
argon laser. YFP was imaged with a 530–600 nm band-
pass filter, CMAC with a 420–500 nm bandpass filter.
Flow cytometry
Epics XL (Beckman Coulter, Fullerton, CA) and FACS-
can (Becton Dickinson, Franklin Lakes, NJ) flow cyt-
ometers were used to assess expression of GFP, RFP, HAand V5 tagged proteins in infected and transfected cells
using a 525 nm or a 530 nm band pass emission filter.
20,000 cells from each sample were analyzed after trypsi-
nization and suspension in HBSS. Propidium iodide
(Sigma) was added to cell suspension at a concentration
of 1ug/ml to exclude dead cells in FACS analysis.
Additional file
Additional file 1: Figure S1. The expression PiT2K522E on productively
GALV-GFP infected MDTF cells expressing PiT2K522E tagged with HA
epitope. A. Uninfected MDTFPiT2K522E-HA cells. B. MDTFPiT2K522E cells
transduced with GALV-GFP viruses three weeks after initial viral exposure.
The cells were unstained (left) or stained (right) with anti-HA monoclonal
antibodies and isotope specific secondary antibody conjugated with
R-phyoerythrinan and analyzed by flow cytometry. The x-axis represents
MFI of GFP expression and the y-axis represents MFI of HA expression on
the cell surface. The experiment was performed three independent times,
and images are from one representative experiment.
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